Envue Eye & Laser Center provides vision correction and cataract surgery services. The center offers various procedures including LASIK, SMILE, PRK, EVO ICL, RLE, and cataract surgery. The services are customized to meet the unique needs of each patient.

Envue Eye & Laser Center

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Bernard Chauvin

Bausch + Lomb Corporation

CooperVision is a company that manufactures and sells contact lenses and related products.

CooperVision

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, Europe, Latin America, Asia, Oceania, and Africa. It operates in five segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale segment engages in the manufacture and wholesale distribution of luxury and sports eyewear. The Retail segment retails luxury and sports eyewear. The Lenses and Optical Instruments segment offers lenses and small equipment, including Varilux progressive lenses; Crizal antireflective, anti-smudge, and antistatic lenses; Transitions photochromic lenses; Eyezen lenses for users of computers, tablets, smartphones, and other connected devices; Xperio polarized sun lenses; and Nikon and Kodak corrective lens brands. It also provides lens edging and mounting instruments for opticians and prescription laboratories; optometry instruments for eye care professionals, schools, occupational medicine centers, military, and other institutions; and Transitions Signature Gen 8 photochromic lens, as well as develops solutions for online sales of optical products. The Equipment segment offers digital surfacing machines and lens coating machines to prescription laboratories, integrated optical chains, and lens manufacturers. The Sunglasses and Readers segment provides non-prescription sunglasses and reading glasses under the Foster Grant, Gargoyles, Magnivision, Corinne McCormack, Monkey Monkey, Ryders Eyewear, and SolarShield brands; Reebok, Steve Madden, Betsey Johnson, Nine West, Dockers, French Connection, Ironman, Rawlings, Bodyglove, Panama Jack, Marvel, and Disney; Bolon, Molsion, Qina, and Prosun brands; and Mujosh and Aojo brands. It has a network of 490 prescription laboratories and edging-mounting facilities. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

Metric
Company Name	Envue Eye & Laser Center	Bausch + Lomb Corporation	CooperVision	EssilorLuxottica Société anonyme
Symbol		BLCO		EL
MSH ID	COM:ENVUEEYE	COM:BAUSCH	COM:COOPERVISION	COM:ESSILORLUXOTTICA
Market	PRIVATE	STOCKS	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare	Healthcare & Health Services	Healthcare
Industry	Medical Services	Medical - Instruments & Supplies	Medical Devices and Supplies	Medical - Instruments & Supplies
Country	US	CA	US	FR
Stage
Employee Count		13.30K	10.00K	151.29K
Website	envueeye.com	bausch.com	coopervision.com	essilorluxottica.com
LinkedIn
Founders

Metric
Market Cap	5.43B		95.27B
Enterprise Value
Monthly Web Traffic		402.65K
Web Traffic Growth		0.33
Valuation
Raised Capital

Metric
Revenue	4.15B	26.82B
Revenue (LTM)
Revenue (NTM)
Gross Profit	2.50B	16.97B
EBITDA	601M	6.55B
Operating Income	130M	3.41B
Net Income	-260M	2.42B
EPS	-0.74	5.40
Diluted EPS	-0.74	5.37
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.96	0.63
Operating Profit Margin	0.12	0.13
EBITDA Margin	0.14	0.24
Net Profit Margin	-0.00	0.09
Return on Equity	0.02	0.06
Return on Assets	-0.00	0.04
Return on Capital Employed	0.05	0.07

COM:ENVUEEYE

Envue Eye & Laser Center

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-23.54	69.77
P/B Ratio	0.71	2.11
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.64	3.82
EV Multiple	17.67	15.71

Metric
Days Sales Outstanding	72.01	97.64
Days Payables Outstanding	82.99	186.23
Days Inventory Outstanding	1.62K	120.02
Operating Cycle	1.70K	175.84
Cash Conversion Cycle	1.07K	76.33
Asset Turnover	0.34	0.42

Metric
Operating Cash Flow	-17M	5.13B
Free Cash Flow	-198M	3.52B
Cash Flow to Debt	0.05	0.57
Operating Cash Flow/Sales	0.13	0.19
Free Cash Flow Yield	-0.00	0.02

Metric
Cash & Equivalents	331M	2.70B
Accounts Receivable	-121M	-167.94M
Inventory	1.03B	2.90B
Goodwill	4.58B	31.97B
Debt to Capitalization	1.05	0.22
Debt to Assets	0.34	0.20
Current Ratio	1.78	0.92
Quick Ratio	1.03	0.72

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.02	0.01
R&D to Revenue	0.08	0.02
SG&A to Revenue		0.48